BillsHH.R. 9077
To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Stage
In committee
Latest action
Referred to the House Committee on Energy and Commerce.
May 29, 2026
Committees
- PrimaryEnergy and Commerce Committee
Action history
- May 29, 2026Introduced in House
- May 29, 2026Introduced in House
- May 29, 2026Referred to the House Committee on Energy and Commerce.